'Watchful waiting' is a viable option for prostate cancer patients with low-risk tumors

BOSTON -- Appropriately selected prostate cancer patients, including older men and men with small, low-risk tumors, may safely defer treatment for many years with no adverse consequences, according to a new study in the Journal of Clinical Oncology (JCO). Led by researchers at Beth Israel Deaconess Medical Center (BIDMC), the study appears online today.

Read the whole article on Science Blog

More from Science Blog